Hydroxyurea Remains Effective Long-Term in Children With Sickle Cell Disease

(MedPage Today) -- Hydroxyurea, a myelosuppressive agent that has been a standard treatment in sickle cell disease (SCD) for decades, remains effective over the long term in children with the disease, according to a single-center, real-world study...